Entity Common Stock, Shares Outstanding of Ambrx Biopharma Cayman, Inc. from 31 Dec 2021 to 07 Aug 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Ambrx Biopharma Cayman, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Dec 2021 to 07 Aug 2023.
  • Ambrx Biopharma Cayman, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 07 Aug 2023 was 434,070,056.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)

Ambrx Biopharma Cayman, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2023 434,070,056 07 Aug 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 386,486,014 24 Mar 2023 10-K 30 Mar 2023 2022 FY
Q4 2021 300,015,224 31 Dec 2021 20-F 26 Apr 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.